Viemed Healthcare, Inc.
Search documents
Baxter International (BAX) Q4 Earnings Lag Estimates
ZACKS· 2026-02-12 14:35
分组1 - Baxter International reported quarterly earnings of $0.44 per share, missing the Zacks Consensus Estimate of $0.53 per share, and down from $0.58 per share a year ago, representing an earnings surprise of -17.42% [1] - The company posted revenues of $2.97 billion for the quarter, surpassing the Zacks Consensus Estimate by 6.44%, compared to year-ago revenues of $2.75 billion [2] - Baxter shares have increased approximately 16.5% since the beginning of the year, outperforming the S&P 500's gain of 1.4% [3] 分组2 - The current consensus EPS estimate for the coming quarter is $0.50 on revenues of $2.64 billion, and for the current fiscal year, it is $2.33 on revenues of $11.28 billion [7] - The Zacks Industry Rank indicates that the Medical - Products sector is currently in the bottom 33% of over 250 Zacks industries, suggesting potential challenges for stock performance [8]
Viemed Healthcare Announces First Quarter 2025 Earnings Conference Call Details
Newsfilter· 2025-04-22 20:30
Company Overview - Viemed Healthcare, Inc. is a national leader in respiratory care and technology-enabled home medical equipment services in the United States [3] - The company specializes in post-acute respiratory healthcare equipment and services, including non-invasive ventilators, sleep therapy, and staffing [3] Upcoming Events - Viemed will host its First Quarter 2025 Earnings Conference Call on May 8, 2025, at 11:00 a.m. EDT [1] - Interested parties can participate via a toll-free number or an international dial-in, and a live audio webcast will be available [2] Contact Information - For further inquiries, contact Tripp Sullivan at SCR Partners, LLC or Todd Zehnder, Chief Operating Officer of Viemed Healthcare [4]
Viemed Healthcare: Remaining Bullish Due To Strong Forward-Looking EPS Revisions
Seeking Alpha· 2025-04-21 02:13
Core Viewpoint - Viemed Healthcare, Inc. (NASDAQ: VMD) is a US-based provider of home medical respiratory equipment, which has been identified as an undervalued stock with strong fundamentals and potential for income generation through investment strategies [1]. Company Summary - The stock was trading at approximately $7.35 per share over seven months ago when the bullish stance was initiated [1]. - The company focuses on acquiring undervalued profitable stocks with strong balance sheets and minimal debt, indicating a solid financial position [1]. Investment Strategy - The investment approach includes writing calls against positions to generate additional income when opportunities arise [1]. - Risk management is emphasized through position sizing and the use of trailing stop losses over time, showcasing a disciplined investment strategy [1].